Immuron Limited
ASX: IMC
Immuron Ltd. is a biopharmaceutical company focused on developing and commercializing a new type of specifically targeted polyclonal antibodies. It has two main operating segments: Hyper-immune Products and Research and Development. The Hyper-immune Products segment covers revenue and costs related to Travelan and Protectyn. The Research and Development segment cove
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
PG Weekly Pick
A$100.00
Already a subscriber?
Sign in to read this report.
Required subscription
PG Weekly Pick
Receive one high-conviction ASX stock idea every week, backed by detailed research, risk analysis, and a clear investment thesis designed to help you focus on quality opportunities.
- ✓ One Premium ASX Stock Pick Weekly
- ✓ Delivered Every Friday
- ✓ Buy / Hold / Sell Guidance & Risk Rating
- ✓ Full Historical Pick Access
A$100.00/ 1 months
Risk:High
Subscribe Now →
